Fuse Oncology Inc is a biotechnology company focused on developing targeted therapies for oncology indications driven by oncogenic fusion proteins and other genetic drivers. The company applies molecular and translational oncology approaches to discover and advance precision medicines intended to selectively target cancer-specific drivers and improve patient outcomes across fusion-driven tumor types.
Leadership & Board
Current Number of Employees28
Current LinkedIn Followers3,007
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$9M
Total Amount Raised$9M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$9M
Latest Funding Amount$9M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Fuse Oncology Inc had 28 employees as of May 25, 2026. The number of employees increased by 0 (0.00%) week-over-week.
28Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Fuse Oncology Inc had 3,007 followers as of May 25, 2026. The number of followers decreased by 4 (0.13%) week-over-week.
3,007Latest Followers Count
4(-0.13%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.